MentionFox
Home › Executive changes › Lifecore Biomedical, Inc. \De\
Leadership changes · LFCR · SEC Form 8-K, Item 5.02

Leadership changes at Lifecore Biomedical, Inc. \De\ (2026)

Before you join, sell to or invest in Lifecore Biomedical, Inc. \De\

MentionFox check on Lifecore Biomedical, Inc. \De\: only 2 sources on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/lifecore-biomedical-inc-de

  • Note: Layoff plan disclosed Jul 2024 (about 46 employees) (filing)

New since last check: Layoff plan disclosed Jul 2024 (about 46 employees) (filing, first seen 14 November 2026).

Check Lifecore Biomedical, Inc. \De\ before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Lifecore Biomedical, Inc. \De\?

Who joined and who left Lifecore Biomedical, Inc. \De\ (LFCR)? 1 filing reported on 2026-06-05, each cited to the company's own filing.

As of November 14, 2026, Lifecore Biomedical, Inc. \De\ has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 5, 2026 (Form 8-K, June 5, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Legion Partners, L.P. I also filed stake reports on 2 other companies ↓

Sell to companies like Lifecore Biomedical, Inc. \De\? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-06-05

Lifecore Biomedical, Inc. \De\ reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-05. Every row below is cited to the filing it comes from, and this page adds each new change as Lifecore Biomedical, Inc. \De\ files it.

Layoffs on record: about 46 jobs, latest 2024-07-12 (layoff filings and notices).

Also on the record for Lifecore Biomedical, Inc. \De\

DateRecordFigureOur pageSource
September 29, 2026Stake report, Schedule 13D/A, by Wynnefield Partners Small Cap Value, L.P. I14.3% of the class5%+ stakesSource
September 28, 2026Stake report, Schedule 13D/A, by Legion Partners Asset Management, LLC17.3% of the class5%+ stakesSource
July 29, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.4% of the class5%+ stakesSource
July 2, 2026Stake report, Schedule 13D/A, by 22NW Fund, LP6.74% of the class5%+ stakesSource
July 2, 2026Stake report, Schedule 13D/A, by Legion Partners Asset Management, LLC17.1% of the class5%+ stakesSource
April 27, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.4.98% of the class5%+ stakesSource
January 21, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.1% of the class5%+ stakesSource
October 17, 2025Stake report, Schedule 13G/A, by BlackRock, Inc.4.9% of the class5%+ stakesSource
July 17, 2025Stake report, Schedule 13G, by BlackRock, Inc.5% of the class5%+ stakesSource

Selling to them or working with them? See who runs Lifecore Biomedical, Inc. \De\ now and the warning signs.

Watch Lifecore Biomedical, Inc. \De\: email me the next time it files something

Free to see. No signup.

Keep reading

More on Lifecore Biomedical, Inc. \De\ and the records around it.

Lifecore Biomedical, Inc. \De\ elsewhere on the record

Companies that share a holder

Want the whole picture on Lifecore Biomedical, Inc. \De\?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Lifecore Biomedical, Inc. \De\: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Lifecore Biomedical, Inc. \De\ covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    11 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-06-05Reportednot named in the filing8-K, 2026-06-05
Selling to Lifecore Biomedical, Inc. \De\?

New leaders reset buying decisions — get the Full Report on Lifecore Biomedical, Inc. \De\: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Lifecore Biomedical, Inc. \De\

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Lifecore Biomedical, Inc. \De\, with the record behind each one.

Find candidates like senior executive at Lifecore Biomedical, Inc. \De\

Every change, in the filing's words

Filed 2026-06-05 · 8-K

Reported

By its terms, the 2026 Plan will become effective on October 16, 2026 (the "Effective Date") at which time the Company's 2019 Stock Incentive Plan (the "2019 Plan") will expire by its terms.

Also stated in this filing

  • On June 4, 2026, Lifecore Biomedical, Inc. (the "Company") held its 2026 annual meeting of stockholders (the "Annual Meeting").
  • At the Annual Meeting, Company's stockholders approved Proposal No. 4: Approval of the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan (the "2026 Plan").
  • The Board of Directors adopted the 2026 Plan on April 22, 2026, on the Compensation Committee's recommendation, subject to stockholder approval.
  • The aggregate number of shares of the Company's Common Stock available for issuance under the 2026 Plan will be (i) 2,500,000 shares of Common Stock, plus (ii) any shares of Common Stock that are represented by awards granted under the 2019 Plan that are forfeited, expire or are cancelled without delivery of shares or which result in the forfeiture of shares back to the Company on or after the Effective Date.

Tools for this story

Each opens in a new tab, filled in for Lifecore Biomedical, Inc. \De\. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/lifecore-biomedical-inc-de
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Lifecore Biomedical, Inc. \De\?. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/lifecore-biomedical-inc-de